Loading…
CIK 0001583977 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("cormorant-asset-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $182.1M | 8.4%Prev: 11.4% | 1,350,000 SH | Increased-600,000 SH |
| ALUMIS INC | COM | $35.5M | 1.6%Prev: 0.6% | 3,635,596 SH | Increased+1,488,200 SH |
| AMYLYX PHARMACEUTICALS INC | COM | $4.8M | 0.2%Prev: 0.5% | 400,000 SH | Decreased-100,000 SH |
| ARCUTIS BIOTHERAPEUTICS INC | COM | $14.5M | 0.7%Prev: 1.0% | 500,000 SH | Decreased-275,000 SH |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $21.3M | 1.0% | 100,000 SH | New |
| AXSOME THERAPEUTICS INC | COM | $13.7M | 0.6%Prev: 0.8% | 75,000 SH | Increased-25,000 SH |
| BIOAGE LABS INC | COM | $27.0M | 1.2%Prev: 0.9% | 2,040,605 SH | Increased-100,000 SH |
| BIOHAVEN LTD | COM | $113K | 0.0%Prev: 0.0% | 10,000 SH | Decreased |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $223.8M | 10.4%Prev: 14.3% | 17,878,594 SH | Increased |
| BRIDGEBIO PHARMA INC | COM | $91.8M | 4.2%Prev: 5.0% | 1,200,000 SH | Increased-200,000 SH |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | $82.7M | 3.8%Prev: 4.4% | 1,059,331 SH | Increased |
| CABALETTA BIO INC | COM | $9.6M | 0.4%Prev: 0.8% | 4,400,000 SH | Decreased-600,000 SH |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $33.1M | 1.5%Prev: 3.2% | 1,325,000 SH | Decreased-600,000 SH |
| COGENT BIOSCIENCES INC | COM | $8.0M | 0.4% | 225,000 SH | New |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $19.1M | 0.9%Prev: 2.1% | 2,344,971 SH | Decreased-30,029 SH |
| CRINETICS PHARMACEUTICALS IN | COM | $14.0M | 0.6%Prev: 1.1% | 300,000 SH | Decreased-100,000 SH |
| EDGEWISE THERAPEUTICS INC | COM | $81.5M | 3.8%Prev: 4.5% | 3,285,000 SH | Increased-725,000 SH |
| ENGENE HOLDINGS INC | COM | $36.1M | 1.7%Prev: 1.1% | 4,000,000 SH | Increased+1,676,405 SH |
| EYEPOINT INC | COM NEW | $151.0M | 7.0% | 8,265,000 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $16.5M | 0.8%Prev: 1.9% | 1,300,000 SH | Decreased-616,439 SH |
| INSMED INC | COM PAR $.01 | $47.9M | 2.2%Prev: 4.3% | 275,000 SH | Decreased-155,000 SH |
| INVESCO QQQ TR | UNIT SER 1 | $153.6M | 7.1% | 250,000 SH | New |
| ISHARES TR | RUSSELL 2000 ETF | $123.1M | 5.7% | 500,000 SH | New |
| JANUX THERAPEUTICS INC | COM | $9.0M | 0.4%Prev: 1.4% | 650,000 SH | Decreased-200,000 SH |
| MBX BIOSCIENCES INC | COM | $35.3M | 1.6%Prev: 1.5% | 1,120,000 SH | Increased-105,000 SH |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $57.4M | 2.7%Prev: 1.0% | 4,355,433 SH | Increased+2,361,260 SH |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $35.1M | 1.6%Prev: 4.3% | 1,000,000 SH | Decreased-1,175,000 SH |
| OLEMA PHARMACEUTICALS INC | COM | $68.8M | 3.2% | 2,750,000 SH | New |
| ORUKA THERAPEUTICS INC | COM | $16.2M | 0.7%Prev: 0.7% | 533,340 SH | Increased |
| PHARVARIS N V | COM | $30.1M | 1.4%Prev: 2.3% | 1,083,000 SH | Decreased-280,200 SH |
| PRAXIS PRECISION MEDICINES I | COM NEW | $280.0M | 12.9%Prev: 3.7% | 950,000 SH | Increased-50,000 SH |
| RAPPORT THERAPEUTICS INC | COM | $91.9M | 4.2%Prev: 6.5% | 3,027,521 SH | Decreased-165,000 SH |
| SPDR SERIES TRUST | STATE STREET SPD | $121.9M | 5.6% | 1,000,000 SH | New |
| TARSUS PHARMACEUTICALS INC | COM | $20.5M | 0.9%Prev: 1.2% | 250,000 SH | Increased-50,000 SH |
| VAXCYTE INC | COM | $5.8M | 0.3%Prev: 0.4% | 125,000 SH | Decreased-50,000 SH |
| 13F-HR |
| 0001583977-26-000007 |
| $1.95B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001583977-25-000007 | $1.34B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001583977-26-000002 | $1.99B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001583977-25-000005 | $1.33B | View |